Well done BOT!
Mr Callahan added, “In addition to confirming the significant potential of BTX 1204 for atopic dermatitis, these results again provide further evidence of the anti-inflammatory effects of synthetic cannabidiol. Inflammation is a consistent theme across the other common skin diseases that Botanix is targeting. These results continue to validate and support the broader potential of the Botanix product portfolio.”
The sky is the limit
Well done BOT! Mr Callahan added, “In addition to confirming the...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |